Inflammatory breast carcinoma as a model of accelerated self-metastatic expansion by intravascular growth

per Vermeulen, P B, Van Laere, S J, Dirix, L Y
Publicat 2009

High endothelial cell proliferation index and high microvessel density in vascular hotspots suggest an active angiogenic process in human colorectal adenocarcinomas. Angiogenesis G...

per Vermeulen, P. B., Dirix, L. Y., Van Marck, E., Van Oosterom, A. T.
Publicat 1996

Serum vascular endothelial growth factor load and interleukin-6 in cancer patients – reply

per Salgado, R, Benoy, I, Weytjens, R, Vermeulen, P B, Dirix, L Y
Publicat 2000

Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?

per Dirix, L. Y., Van Dam, P. A., Prove, A. M., Vermeulen, P. B.
Publicat 2010

Tallimustine in advanced previously untreated colorectal cancer, a phase II study.

per Punt, C. J., Humblet, Y., Roca, E., Dirix, L. Y., Wainstein, R., Polli, A., Corradino, I.
Publicat 1996

Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients

per Salgado, R, Vermeulen, P B, Benoy, I, Weytjens, R, Huget, P, Marck, E Van, Dirix, L Y
Publicat 1999

Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.

per Steward, W. P., Scarffe, J. H., Dirix, L. Y., Chang, J., Radford, J. A., Bonnem, E., Crowther, D.
Publicat 1990

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype

per Van der Auwera, I, Limame, R, van Dam, P, Vermeulen, P B, Dirix, L Y, Van Laere, S J
Publicat 2010

Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study

per Awada, A, Albanell, J, Canney, P A, Dirix, L Y, Gil, T, Cardoso, F, Gascon, P, Piccart, M J, Baselga, J
Publicat 2008

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.

per Dirix, L. Y., Vermeulen, P. B., Pawinski, A., Prové, A., Benoy, I., De Pooter, C., Martin, M., Van Oosterom, A. T.
Publicat 1997

Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer

per Salgado, R, Benoy, I, Weytjens, R, Van Bockstaele, D, Van Marck, E, Huget, Ph, Hoylaerts, M, Vermeulen, P, Dirix, L Y
Publicat 2002

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group.

per Sulkes, A., Smyth, J., Sessa, C., Dirix, L. Y., Vermorken, J. B., Kaye, S., Wanders, J., Franklin, H., LeBail, N., Verweij, J.
Publicat 1994

Real-time RT–PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast canc...

per Benoy, I H, Elst, H, Philips, M, Wuyts, H, Van Dam, P, Scharpé, S, Van Marck, E, Vermeulen, P B, Dirix, L Y
Publicat 2006

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer

per Dirix, L Y, Salgado, R, Weytjens, R, Colpaert, C, Benoy, I, Huget, P, van Dam, P, Prové, A, Lemmens, J, Vermeulen, P
Publicat 2002

Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study.

per Vermeulen, P. B., Verhoeven, D., Fierens, H., Hubens, G., Goovaerts, G., Van Marck, E., De Bruijn, E. A., Van Oosterom, A. T., Dirix, L. Y.
Publicat 1995

Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer

per Vermeulen, P B, Eynden, G G Van den, Huget, P, Goovaerts, G, Weyler, J, Lardon, F, Marck, E Van, Hubens, G, Dirix, L Y
Publicat 1999

Real-time RT–PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer

per Benoy, I H, Elst, H, Van der Auwera, I, Laere, S Van, Dam, P van, Marck, E Van, Scharpé, S, Vermeulen, P B, Dirix, L Y
Publicat 2004

NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation

per Van Laere, S J, Van der Auwera, I, Van den Eynden, G G, van Dam, P, Van Marck, E A, Vermeulen, P B, Dirix, L Y
Publicat 2007

First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours

per Van der Auwera, I, Cao, Y, Tille, J C, Pepper, M S, Jackson, D G, Fox, S B, Harris, A L, Dirix, L Y, Vermeulen, P B
Publicat 2006

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

per Miles, D W, de Haas, S L, Dirix, L Y, Romieu, G, Chan, A, Pivot, X, Tomczak, P, Provencher, L, Cortés, J, Delmar, P R, Scherer, S J
Publicat 2013